These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8767843)

  • 1. Quinazolinone derivatives: synthesis and binding evaluation on cholecystokinin receptors.
    Varnavas A; Lassiani L; Luxich E; Zacchigna M; Boccù E
    Farmaco; 1996 May; 51(5):333-9. PubMed ID: 8767843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolone derivatives: synthesis and binding evaluation on cholecystokinin receptors.
    Varnavas A; Lassiani L; Luxich E; Zacchigna M; Boccù E; Pichierri F
    Farmaco; 1996 May; 51(5):341-50. PubMed ID: 8767844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands.
    Yu MJ; McCowan JR; Mason NR; Deeter JB; Mendelsohn LG
    J Med Chem; 1992 Jul; 35(14):2534-42. PubMed ID: 1635055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A; Anzini M; Vomero S; Menziani MC; De Benedetti PG; Sbacchi M; Clarke GD; Mennuni L
    J Med Chem; 1996 Feb; 39(4):860-72. PubMed ID: 8632410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel glutamic acid derived cholecystokinin receptor ligands.
    Freidinger RM; Whitter WL; Gould NP; Holloway MK; Chang RS; Lotti VJ
    J Med Chem; 1990 Feb; 33(2):591-5. PubMed ID: 2299627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Oxopyrrolidines and 6-oxoperhydropyrrolo[1,2-a]pyrazines as templates in the search for nonpeptide cholecystokinin ligands.
    Martín-Martínez M; Ballaz S; Latorre M; Herranz R; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):782-6. PubMed ID: 9621412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of thiadiazol derivatives of 4(3H)-quinazolinone as potential antimicrobial agents.
    Khalil MA; Habib NS
    Farmaco Sci; 1987 Dec; 42(12):973-8. PubMed ID: 3449395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal anthranoyl-anthranilic acid derivatives and their evaluation on CCK receptors.
    Varnavas A; Lassiani L; Luxich E; Valenta V
    Farmaco; 2000 Apr; 55(4):293-302. PubMed ID: 10966161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological investigation of some novel 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones as H1-receptor blockers.
    Alagarsamy V; Venkatesaperumal R; Vijayakumar S; Angayarkanni T; Pounammal P; Senthilganesh S; Kandeeban S
    Pharmazie; 2002 May; 57(5):306-7. PubMed ID: 12061252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
    Ursini A; Capelli AM; Carr RA; Cassarà P; Corsi M; Curcuruto O; Curotto G; Dal Cin M; Davalli S; Donati D; Feriani A; Finch H; Finizia G; Gaviraghi G; Marien M; Pentassuglia G; Polinelli S; Ratti E; Reggiani AM; Tarzia G; Tedesco G; Tranquillini ME; Trist DG; Van Amsterdam FT
    J Med Chem; 2000 Oct; 43(20):3596-613. PubMed ID: 11020274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation.
    Pirotte B; de Tullio P; Podona T; Diouf O; Dewalque D; Neven P; Masereel B; Caignard P DH; Renard P; Delarge J
    Eur J Pharm Sci; 1998 Dec; 7(1):29-40. PubMed ID: 9845775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
    Hunter JC; Suman-Chauhan N; Meecham KG; Dissanayake VU; Hill DR; Pritchard MC; Kneen CO; Horwell DC; Hughes J; Woodruff GN
    Mol Pharmacol; 1993 Apr; 43(4):595-602. PubMed ID: 8474432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers.
    Alagarsamy V
    Pharmazie; 2004 Oct; 59(10):753-5. PubMed ID: 15544052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S; Smith AJ; Chapman KL; Fletcher AE; Kemp JA; Marshall GR; Hargreaves RJ; Ryecroft W; Iversen LL; Iversen SD
    Mol Pharmacol; 1994 Nov; 46(5):943-8. PubMed ID: 7969084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Whitter WL; Veber DF; Freidinger RM; Chang RS; Chen TB; Lotti VJ
    J Med Chem; 1990 Jan; 33(1):450-5. PubMed ID: 2153212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthranilic acid derivatives: a new class of non-peptide CCK1 receptor antagonists.
    Varnavas A; Lassiani L; Valenta V; Berti F; Mennuni L; Makovec F
    Bioorg Med Chem; 2003 Mar; 11(5):741-51. PubMed ID: 12538004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.